Compound Detail
CHEMBL220360
TARANABANT 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
C[C@H](NC(=O)C(C)(C)Oc1ccc(C(F)(F)F)cn1)[C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1
Basic Information
| ChEMBL ID | CHEMBL220360 |
| Name | TARANABANT |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | QLYKJCMUNUWAGO-GAJHUEQPSA-N |
6
Targets
32
Activities
3
Assay Types
20
PK Parameters
20
Publications
6
Known Names
4
Indications
1
Mechanisms
Molecular Properties
516.0
MW (Da)
6.31
ALogP
4
HBA
1
HBD
75.0
PSA (Ų)
0.38
QED
2
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cannabinoid CB1 receptor inverse agonist | INVERSE AGONIST | Cannabinoid receptor 1 | ✓ | ✓ |
Indications
Diabetes Mellitus, Type 2 Obesity Tobacco Use Disorder Urinary Incontinence
Activity Summary
IC50 28 meas. best 10.03
EC50 2 meas. best 8.62
Ki 2 meas. best 9.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cannabinoid receptor 1 CHEMBL218 | IC50 | 10.03 | 9.1547 | 0.1 | 19 |
| Cannabinoid receptor 1 CHEMBL218 | Ki | 9.52 | 9.52 | 0.3 | 1 |
| Cannabinoid receptor 1 CHEMBL3571 | IC50 | 9.52 | 9.295 | 0.3 | 2 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 9.23 | 9.23 | 0.6 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 9.03 | 9.03 | 0.9 | 1 |
| Cannabinoid receptor 1 CHEMBL218 | EC50 | 8.62 | 8.62 | 2.4 | 2 |
| Cannabinoid receptor 2 CHEMBL253 | IC50 | 6.54 | 6.3875 | 285.0 | 4 |
| Cannabinoid receptor 2 CHEMBL253 | Ki | 6.54 | 6.54 | 290.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.85 | 4.85 | 14200.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1394.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 412.5 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 33.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 40.83 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 490.0 | nM | Rattus norvegicus |
| Cmax | 697.73 | nM | Rattus norvegicus |
| Cmax | 910.92 | nM | Rattus norvegicus |
| F | 31.0 | % | Canis lupus familiaris |
| F | 31.0 | % | Macaca mulatta |
| F | 74.0 | % | Rattus norvegicus |
| F | 74.0 | % | Rattus norvegicus |
| F | 67.6 | % | Rattus norvegicus |
| T1/2 | 14.0 | hr | Canis lupus familiaris |
| T1/2 | 3.6 | hr | Macaca mulatta |
| T1/2 | 2.7 | hr | Rattus norvegicus |
| T1/2 | 2.7 | hr | Rattus norvegicus |
| T1/2 | 14.8 | hr | Rattus norvegicus |
| T1/2 | 2.76 | hr | Rattus norvegicus |
| T1/2 | 72.0 | hr | Homo sapiens |
| Tmax | 0.5 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine